Erich Rajkovic

477 total citations
16 papers, 325 citations indexed

About

Erich Rajkovic is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Erich Rajkovic has authored 16 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Erich Rajkovic's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (6 papers). Erich Rajkovic is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (6 papers). Erich Rajkovic collaborates with scholars based in Germany, Austria and United Kingdom. Erich Rajkovic's co-authors include Uwe Reusch, Martin Treder, Joachim Koch, Jens Pahl, Annette Arnold, Thorsten Gantke, Adelheid Cerwenka, Kristina Ellwanger, Andreas J. Kungl and Ivica Fucek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Erich Rajkovic

14 papers receiving 307 citations

Peers

Erich Rajkovic
Selvi Ramasamy United States
Sunnie Hsiung United States
Laura Cons Switzerland
Ufuk Karakus Switzerland
Alexandra M. Terry Australia
Patrizia Murer Switzerland
Marielle Chiron France
Bram ten Cate Netherlands
Masaru Taniguchi Japan
J L Lucich United States
Selvi Ramasamy United States
Erich Rajkovic
Citations per year, relative to Erich Rajkovic Erich Rajkovic (= 1×) peers Selvi Ramasamy

Countries citing papers authored by Erich Rajkovic

Since Specialization
Citations

This map shows the geographic impact of Erich Rajkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erich Rajkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erich Rajkovic more than expected).

Fields of papers citing papers by Erich Rajkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erich Rajkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erich Rajkovic. The network helps show where Erich Rajkovic may publish in the future.

Co-authorship network of co-authors of Erich Rajkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Erich Rajkovic. A scholar is included among the top collaborators of Erich Rajkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erich Rajkovic. Erich Rajkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
El-Khoueiry, Anthony B., Juanita Lopez, Omar Saavedra, et al.. (2022). 754P A phase I/IIa dose escalation study of AFM24 in patients with epidermal growth factor receptor-expressing (EGFR) solid tumors: Results from phase I. Annals of Oncology. 33. S889–S889.
2.
3.
Hintzen, Gabriele, Susanne Wingert, Pilar Nava-Parada, et al.. (2022). 729 Targeting epidermal growth factor receptor (EGFR)-expressing solid tumors with AFM24, a novel CD16A bispecific innate cell engager: comprehensive correlative science findings from a phase 1 study. Regular and Young Investigator Award Abstracts. A762–A762.
4.
5.
Wingert, Susanne, Uwe Reusch, Stefan Knackmuss, et al.. (2021). Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors. mAbs. 13(1). 1950264–1950264. 50 indexed citations
6.
Reusch, Uwe, Susanne Wingert, Stefan Knackmuss, et al.. (2020). Abstract 5659: AFM24, a bispecific EGFR/CD16A innate cell engager with the potential to overcome resistance to current targeted treatments for EGFR-positive malignancies. Cancer Research. 80(16_Supplement). 5659–5659. 4 indexed citations
7.
Duell, Johannes, Margarete M. Karg, Uwe Reusch, et al.. (2019). Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11. Journal of Immunotherapy. 42(5). 180–188. 15 indexed citations
8.
Ellwanger, Kristina, Uwe Reusch, Ivica Fucek, et al.. (2019). Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity. mAbs. 11(5). 899–918. 50 indexed citations
9.
Pahl, Jens, Joachim Koch, Annette Arnold, et al.. (2018). CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells. Cancer Immunology Research. 6(5). 517–527. 104 indexed citations
10.
Reusch, Uwe, Susanne Wingert, Katja Klausz, et al.. (2018). Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma. Blood. 132(Supplement 1). 1927–1927. 26 indexed citations
11.
Kerber, A., Michael Kluge, Uwe Reusch, et al.. (2017). EGFR/CD16A tetravalent bispecific antibody AFM24 to engage NK-cells to kill EGFR expressing tumor cells and safety results in cynomolgus monkey studies.. Journal of Clinical Oncology. 35(15_suppl). e14001–e14001. 3 indexed citations
12.
Weinschenk, Toni, Erich Rajkovic, Uwe Reusch, et al.. (2017). Abstract 3753: Identification of antibodies against a novel tumor-associated MHC/peptide-target and generation of highly specific and potent HLA-A*02MMP1-003/CD3 TandAbs. Cancer Research. 77(13_Supplement). 3753–3753. 1 indexed citations
13.
Ellwanger, Kristina, Uwe Reusch, Ivica Fucek, et al.. (2016). Abstract 593: Highly cytotoxic EGFR/CD16A TandAbs specifically recruit NK cells to potently kill various types of solid tumors. Cancer Research. 76(14_Supplement). 593–593. 5 indexed citations
14.
Rajkovic, Erich, et al.. (2014). Bacterial expression and functional reconstitution of human heparanase. Carbohydrate Research. 389. 72–77. 4 indexed citations
15.
Weis, Robert, Erich Rajkovic, Andreas J. Kungl, et al.. (2008). Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Bioorganic & Medicinal Chemistry. 16(24). 10326–10331. 23 indexed citations
16.
Gesslbauer, Bernd, Angelika Rek, S. Fabio Falsone, Erich Rajkovic, & Andreas J. Kungl. (2007). Proteoglycanomics: tools to unravel the biological function of glycosaminoglycans. PROTEOMICS. 7(16). 2870–2880. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Selvi Ramasamy Breakdown of academic impact, for papers by Sunnie Hsiung Breakdown of academic impact, for papers by Laura Cons Breakdown of academic impact, for papers by Ufuk Karakus Breakdown of academic impact, for papers by Alexandra M. Terry Breakdown of academic impact, for papers by Patrizia Murer Breakdown of academic impact, for papers by Marielle Chiron Breakdown of academic impact, for papers by Bram ten Cate Breakdown of academic impact, for papers by Masaru Taniguchi Breakdown of academic impact, for papers by J L Lucich
Rankless by CCL
2026